Inside the White House with D.C.'s most wired reporter. Sign up for Mike Allen's Axios AM.


Eye drug company scores gift in spending bill

Snow falls on Capitol Hill.
Congress extended higher payments for Omeros, a small drug company. Photo: Saul Loeb / AFP via Getty Images

Congress' latest spending package includes a provision to boost Medicare payments for one specific drug: Omidria, which is used in cataract surgery, STAT reports. One Wall Street firm estimated that Omeros, the company that makes Omidria, would have to cut the drug's price by 90% to stay competitive without the enhanced Medicare rate.

Why it matters: The pharmaceutical industry wasn't able to reverse new Medicare donut hole obligations, but Congress wasn't afraid to throw out a small life preserver. The stock price of Omeros soared 36% Thursday on the news.

More stories loading.